Spezielle Trainingstherapie zur Reduktion der Inflammation bei Anti-Jo-1-Syndrom

Abstract

A 46-year-old patient was frequently seen with a medically treated Anti-Jo-1syndrome. The patient had already been treated with azathioprine and oral corticosteroids on account of decreasing lung function, dyspnoea, fatigue, and beginning signs of myositis. Although high doses of steroids and azathioprine were administered, the muscleskeletal syndromes increased steadily. The patient used to be an active long-distance runner (20km), but now was unable to perform that kind of physical exercise. It was decided to start a treatment with the Galileo™ training device for active muscle training of the lower extremities. Before and after three months of training the following assessment was performed: measurement of health-related quality of life (St. Georges respiratory questionnaire, SGRQ), ultrasound measurement of the cross-sectional area of the quadriceps muscle, 6 minute walk test (6 MWT), lung function testing, and assessment of serum markers of inflammation (TNF-alpha, interleukin-8, CRP, CK, myoglobin). After only two months, training with the Galileo™ five times a week has improved the patients conditions dramatically. The training will be continued. © Georg Thieme Verlag KG Stuttgart.